King Wealth Horizon Therapeutics Public LTD CO Transaction History

King Wealth

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $492,800 - $599,550	-5,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$86.24 - $95.92 $86,240 - $95,920	-1,000 Reduced 16.67%	5,000 $468,000
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $193,941 - $257,796	-2,700 Reduced 31.03%	6,000 $552,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $221,100 - $278,487	-3,300 Reduced 27.5%	8,700 $636,000
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $276,150 - $399,650	5,000 Added 71.43%	12,000 $932,000
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $174,090 - $269,920	7,000 New	7,000 $207,000
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $207,000 - $251,730	-9,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $205,290 - $256,320	9,000 New	9,000 $217,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.